<![CDATA[Mundipharma 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=36865>Tue, 14 Apr 2026 02:55:07 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Mundipharma announces patient enrolment completion in Phase III ReSPECT clinical trial for REZZAYO® (rezafungin)]]>https://www.newswire.co.kr/newsRead.php?no=1020399Sun, 12 Oct 2025 11:00:00 +0900<![CDATA[문디파마, 레자요®에 대한 제3상 ReSPECT 임상 시험에서 환자 등록 완료 발표]]>https://www.newswire.co.kr/newsRead.php?no=1020400Sun, 12 Oct 2025 11:00:00 +0900<![CDATA[Orphan Drug Designation Granted to Rezafungin in EU for the Treatment of Invasive Candidiasis]]>https://www.newswire.co.kr/newsRead.php?no=917768Wed, 27 Jan 2021 10:58:08 +0900<![CDATA[Julie Dehaene-Puype and Erik Nordkamp appointed as new regional Commercial Officers for Mundipharma]]>https://www.newswire.co.kr/newsRead.php?no=917478Tue, 19 Jan 2021 17:40:45 +0900